Comment on "Peripheral T Lymphocyte Predicts the Prognosis of Gastric Cancer Patients Undergoing Radical Gastrectomy: A Multicenter Retrospective Cohort Study" [Response to Letter]. [PDF]
Xiao H, Luo J.
europepmc +1 more source
In multiple sclerosis, the disruption of the blood‐spinal cord barrier (BSCB) induced by CXCL13 facilitates the infiltration of inflammatory cells into the central nervous system, resulting in demyelination and neuronal injury. Mechanistically, the deleterious impact of CXCL13 on the BSCB is associated with a reduction in tight junction protein ...
Jingjing Han+10 more
wiley +1 more source
Correction: The intestinal microbiome and metabolome discern disease severity in cytotoxic T-lymphocyte-associated protein 4 deficiency. [PDF]
Chandrasekaran P+19 more
europepmc +1 more source
A Porphyrin Nanomaterial for Photoimmunotherapy for Treatment of Melanoma
The TPC@OVA NPs are developed as dual‐functional nanomaterials combining phototherapy and immunotherapy for melanoma treatment. This system effectively ablates primary tumors, induces immunogenic cell death, promotes dendritic cell maturation, and enhances T cell activation.
Zhuang Fan+6 more
wiley +1 more source
New T-lymphocyte subpopulations and their characteristics: Challenges to the classical division of lymphocyte function. [PDF]
Lewandowski F, Niedźwiedzka-Rystwej P.
europepmc +1 more source
MYC is a transcription factor (TF) that binds DNA near transcriptional start sites (TSSs) and within enhancer elements. Here, unappreciated sites of MYC binding in the vicinity of transcriptional end sites (TESs) of many genes in multiple cell types in association with numerous other TFs are described previously.
Huabo Wang+5 more
wiley +1 more source
Erratum for "Peripheral and intestinal T lymphocyte subsets in dogs with chronic inflammatory enteropathy". [PDF]
europepmc +1 more source
Targeting B and T Lymphocyte Attenuator Regulates Lupus Disease Development in NZB/W Mice. [PDF]
Gherardi L+5 more
europepmc +1 more source
Occlusion of tumor blood vessels represents a promising yet challenging approach in cancer treatment. Herein, supramolecularly engineered platelets conjugated with morphology‐transformable nanoparticles is developed for precise tumor embolization. The engineered platelets actively accumulate at tumor sites following induced blood vessel injury.
Junyan Li+9 more
wiley +1 more source
T lymphocyte‑related immune response and immunotherapy in gastric cancer (Review). [PDF]
Zhang Z, Zhang W, Liu X, Yan Y, Fu W.
europepmc +1 more source